Novel motif:144
From FANTOM5_SSTAR
name: | motif144_AAKCMSGT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0052572 | response to host immune response | 2.843080e-12 |
GO:0002281 | macrophage activation involved in immune response | 8.814760e-9 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 2.167263e-8 |
GO:0006741 | NADP biosynthetic process | 5.375530e-8 |
GO:0002282 | microglial cell activation involved in immune response | 5.654206e-8 |
GO:0052033 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immunity | 9.434578e-8 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 1.063385e-7 |
GO:0060161 | positive regulation of dopamine receptor signaling pathway | 1.076261e-7 |
GO:0006863 | purine base transport | 2.195935e-7 |
GO:0015855 | pyrimidine base transport | 2.270535e-7 |
GO:0048569 | post-embryonic organ development | 2.979716e-7 |
GO:0051383 | kinetochore organization | 3.064916e-7 |
GO:0015851 | nucleobase transport | 4.403906e-7 |
GO:0042632 | cholesterol homeostasis | 5.025530e-7 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 6.471312e-7 |
GO:0035409 | histone H3-Y41 phosphorylation | 7.344917e-7 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 7.344917e-7 |
GO:0051382 | kinetochore assembly | 7.524164e-7 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 9.797346e-7 |
GO:0055088 | lipid homeostasis | 1.010064e-6 |
GO:0070836 | caveola assembly | 1.042415e-6 |
GO:0034111 | negative regulation of homotypic cell-cell adhesion | 1.498099e-6 |
GO:0042953 | lipoprotein transport | 1.640191e-6 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 2.169302e-6 |
GO:0031081 | nuclear pore distribution | 2.169302e-6 |
GO:0015942 | formate metabolic process | 2.286501e-6 |
GO:0051646 | mitochondrion localization | 3.589697e-6 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 5.432470e-6 |
GO:0052200 | response to host defenses | 6.663356e-6 |
GO:0009396 | folic acid-containing compound biosynthetic process | 6.826471e-6 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 7.672178e-6 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 8.751918e-6 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 8.751918e-6 |
GO:0016046 | detection of fungus | 8.751918e-6 |
GO:0006907 | pinocytosis | 8.847010e-6 |
GO:0032971 | regulation of muscle filament sliding | 8.883585e-6 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 9.850825e-6 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 1.061019e-5 |
GO:0015721 | bile acid and bile salt transport | 1.331285e-5 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 1.496285e-5 |
GO:0031959 | mineralocorticoid receptor signaling pathway | 1.698312e-5 |
GO:0071529 | cementum mineralization | 1.754492e-5 |
GO:0046514 | ceramide catabolic process | 1.883830e-5 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 2.400394e-5 |
GO:0015722 | canalicular bile acid transport | 2.470265e-5 |
GO:0060574 | intestinal epithelial cell maturation | 2.572626e-5 |
GO:0034508 | centromere complex assembly | 2.652194e-5 |
GO:0006182 | cGMP biosynthetic process | 2.888794e-5 |
GO:0045359 | positive regulation of interferon-beta biosynthetic process | 2.893504e-5 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 3.139912e-5 |
GO:0006926 | virus-infected cell apoptosis | 3.583498e-5 |
GO:0051354 | negative regulation of oxidoreductase activity | 3.852014e-5 |
GO:0030683 | evasion by virus of host immune response | 3.990828e-5 |
GO:0007628 | adult walking behavior | 4.014859e-5 |
GO:0065004 | protein-DNA complex assembly | 4.024663e-5 |
GO:0006853 | carnitine shuttle | 4.041360e-5 |
GO:0006529 | asparagine biosynthetic process | 4.099051e-5 |
GO:0031116 | positive regulation of microtubule polymerization | 5.001851e-5 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 5.009418e-5 |
GO:0048676 | axon extension involved in development | 5.455545e-5 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 5.494554e-5 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 5.528738e-5 |
GO:0000076 | DNA replication checkpoint | 5.795651e-5 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 6.360660e-5 |
GO:0031579 | membrane raft organization | 6.690624e-5 |
GO:0021509 | roof plate formation | 6.856339e-5 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 7.165671e-5 |
GO:0006790 | sulfur compound metabolic process | 8.145992e-5 |
GO:0060356 | leucine import | 8.470982e-5 |
GO:0006260 | DNA replication | 8.786570e-5 |
GO:0042723 | thiamine-containing compound metabolic process | 8.872516e-5 |
GO:0046521 | sphingoid catabolic process | 9.358777e-5 |
GO:0022408 | negative regulation of cell-cell adhesion | 1.019432e-4 |
GO:0070672 | response to interleukin-15 | 1.052648e-4 |
GO:0060061 | Spemann organizer formation | 1.102564e-4 |
GO:0047497 | mitochondrion transport along microtubule | 1.105659e-4 |
GO:0015918 | sterol transport | 1.299368e-4 |
GO:0031022 | nuclear migration along microfilament | 1.365918e-4 |
GO:0015718 | monocarboxylic acid transport | 1.388294e-4 |
GO:0048554 | positive regulation of metalloenzyme activity | 1.394353e-4 |
GO:0045039 | protein import into mitochondrial inner membrane | 1.394353e-4 |
GO:0006598 | polyamine catabolic process | 1.400465e-4 |
GO:0032439 | endosome localization | 1.401380e-4 |
GO:0032707 | negative regulation of interleukin-23 production | 1.418481e-4 |
GO:0060480 | lung goblet cell differentiation | 1.418481e-4 |
GO:0030208 | dermatan sulfate biosynthetic process | 1.418481e-4 |
GO:0042136 | neurotransmitter biosynthetic process | 1.431101e-4 |
GO:0002275 | myeloid cell activation involved in immune response | 1.440517e-4 |
GO:0014012 | peripheral nervous system axon regeneration | 1.472556e-4 |
GO:0060435 | bronchiole development | 1.724026e-4 |
GO:0072530 | purine-containing compound transmembrane transport | 1.728063e-4 |
GO:0006641 | triglyceride metabolic process | 1.781833e-4 |
GO:0031247 | actin rod assembly | 1.805358e-4 |
GO:0002537 | nitric oxide production involved in inflammatory response | 1.805358e-4 |
GO:0044258 | intestinal lipid catabolic process | 1.807135e-4 |
GO:0018350 | protein esterification | 1.807135e-4 |
GO:0060159 | regulation of dopamine receptor signaling pathway | 1.845243e-4 |
GO:0070541 | response to platinum ion | 1.976511e-4 |
GO:0046653 | tetrahydrofolate metabolic process | 2.001486e-4 |
GO:0032222 | regulation of synaptic transmission, cholinergic | 2.084153e-4 |
GO:0035722 | interleukin-12-mediated signaling pathway | 2.117162e-4 |
GO:0015931 | nucleobase-containing compound transport | 2.170458e-4 |
GO:0051642 | centrosome localization | 2.205875e-4 |
GO:0071105 | response to interleukin-11 | 2.243257e-4 |
GO:0006541 | glutamine metabolic process | 2.322474e-4 |
GO:0006334 | nucleosome assembly | 2.337121e-4 |
GO:0060056 | mammary gland involution | 2.399233e-4 |
GO:0009566 | fertilization | 2.400355e-4 |
GO:0071320 | cellular response to cAMP | 2.428381e-4 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 2.559167e-4 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 2.588206e-4 |
GO:0010722 | regulation of ferrochelatase activity | 2.788148e-4 |
GO:0051292 | nuclear pore complex assembly | 2.956513e-4 |
GO:0016338 | calcium-independent cell-cell adhesion | 2.997304e-4 |
GO:0051450 | myoblast proliferation | 3.077528e-4 |
GO:0032365 | intracellular lipid transport | 3.080281e-4 |
GO:0032929 | negative regulation of superoxide anion generation | 3.088167e-4 |
GO:0034723 | DNA replication-dependent nucleosome organization | 3.088167e-4 |
GO:0006898 | receptor-mediated endocytosis | 3.113644e-4 |
GO:0001774 | microglial cell activation | 3.140420e-4 |
GO:0001300 | chronological cell aging | 3.163037e-4 |
GO:0007262 | STAT protein import into nucleus | 3.249170e-4 |
GO:0015793 | glycerol transport | 3.249170e-4 |
GO:0006639 | acylglycerol metabolic process | 3.345176e-4 |
GO:0009064 | glutamine family amino acid metabolic process | 3.623323e-4 |
GO:0030901 | midbrain development | 3.877694e-4 |
GO:0030301 | cholesterol transport | 3.907769e-4 |
GO:0061143 | alveolar primary septum development | 4.038126e-4 |
GO:0071824 | protein-DNA complex subunit organization | 4.125951e-4 |
GO:0001839 | neural plate morphogenesis | 4.149613e-4 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 4.265288e-4 |
GO:0034373 | intermediate-density lipoprotein particle remodeling | 4.412424e-4 |
GO:0060398 | regulation of growth hormone receptor signaling pathway | 4.418354e-4 |
GO:0032609 | interferon-gamma production | 4.703927e-4 |
GO:0032769 | negative regulation of monooxygenase activity | 4.787824e-4 |
GO:0006290 | pyrimidine dimer repair | 4.840991e-4 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 4.895260e-4 |
GO:0051659 | maintenance of mitochondrion location | 4.912845e-4 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 4.912845e-4 |
GO:0051310 | metaphase plate congression | 4.925270e-4 |
GO:0031077 | post-embryonic camera-type eye development | 5.059629e-4 |
GO:0045638 | negative regulation of myeloid cell differentiation | 5.172739e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 5.254467e-4 |
GO:0035456 | response to interferon-beta | 5.317246e-4 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 5.909108e-4 |
GO:0034374 | low-density lipoprotein particle remodeling | 5.960012e-4 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 6.035557e-4 |
GO:0015849 | organic acid transport | 6.143337e-4 |
GO:0034346 | positive regulation of type III interferon production | 6.502809e-4 |
GO:0006406 | mRNA export from nucleus | 7.095045e-4 |
GO:0033561 | regulation of water loss via skin | 7.187543e-4 |
GO:0000105 | histidine biosynthetic process | 7.187543e-4 |
GO:0046677 | response to antibiotic | 7.199062e-4 |
GO:0035564 | regulation of kidney size | 7.634373e-4 |
GO:0031915 | positive regulation of synaptic plasticity | 7.649268e-4 |
GO:0042755 | eating behavior | 7.900524e-4 |
GO:0031103 | axon regeneration | 8.160116e-4 |
GO:0006760 | folic acid-containing compound metabolic process | 8.199165e-4 |
GO:0044062 | regulation of excretion | 8.361554e-4 |
GO:0006638 | neutral lipid metabolic process | 8.503856e-4 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 8.510800e-4 |
GO:0006405 | RNA export from nucleus | 8.551884e-4 |
GO:0015827 | tryptophan transport | 8.608980e-4 |
GO:0015837 | amine transport | 8.634003e-4 |
GO:0051654 | establishment of mitochondrion localization | 8.925016e-4 |
GO:0033683 | nucleotide-excision repair, DNA incision | 9.042896e-4 |
GO:0016137 | glycoside metabolic process | 9.042896e-4 |
GO:0060395 | SMAD protein signal transduction | 9.813865e-4 |
GO:0090193 | positive regulation of glomerulus development | 9.854970e-4 |
GO:0032055 | negative regulation of translation in response to stress | 9.854970e-4 |
GO:0006620 | posttranslational protein targeting to membrane | 9.854970e-4 |
GO:0006108 | malate metabolic process | 9.956751e-4 |
GO:0042157 | lipoprotein metabolic process | 1.013872e-3 |
GO:0071318 | cellular response to ATP | 1.052751e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 1.053437e-3 |
GO:0060638 | mesenchymal-epithelial cell signaling | 1.072599e-3 |
GO:2000173 | negative regulation of branching morphogenesis of a nerve | 1.080790e-3 |
GO:0019079 | viral genome replication | 1.080961e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.084834e-3 |
GO:0034638 | phosphatidylcholine catabolic process | 1.114776e-3 |
GO:0016125 | sterol metabolic process | 1.121458e-3 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1.151913e-3 |
GO:0003333 | amino acid transmembrane transport | 1.166556e-3 |
GO:0002237 | response to molecule of bacterial origin | 1.180200e-3 |
GO:0030204 | chondroitin sulfate metabolic process | 1.186824e-3 |
GO:0009617 | response to bacterium | 1.196413e-3 |
GO:0035458 | cellular response to interferon-beta | 1.216691e-3 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.221913e-3 |
GO:0006413 | translational initiation | 1.246497e-3 |
GO:0061038 | uterus morphogenesis | 1.317628e-3 |
GO:0006528 | asparagine metabolic process | 1.322341e-3 |
GO:0016139 | glycoside catabolic process | 1.322721e-3 |
GO:0015872 | dopamine transport | 1.373817e-3 |
GO:0046942 | carboxylic acid transport | 1.375015e-3 |
GO:0006869 | lipid transport | 1.405371e-3 |
GO:0009744 | response to sucrose stimulus | 1.437797e-3 |
GO:0035356 | cellular triglyceride homeostasis | 1.475150e-3 |
GO:0007162 | negative regulation of cell adhesion | 1.540146e-3 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 1.570564e-3 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 1.571345e-3 |
GO:0032760 | positive regulation of tumor necrosis factor production | 1.628480e-3 |
GO:0060644 | mammary gland epithelial cell differentiation | 1.687176e-3 |
GO:0045210 | FasL biosynthetic process | 1.745749e-3 |
GO:0042753 | positive regulation of circadian rhythm | 1.748625e-3 |
GO:0030104 | water homeostasis | 1.776326e-3 |
GO:0052509 | positive regulation by symbiont of host defense response | 1.787608e-3 |
GO:0015820 | leucine transport | 1.849287e-3 |
GO:0001840 | neural plate development | 1.851448e-3 |
GO:0021700 | developmental maturation | 1.854365e-3 |
GO:0030853 | negative regulation of granulocyte differentiation | 1.864135e-3 |
GO:0070328 | triglyceride homeostasis | 2.001139e-3 |
GO:0060401 | cytosolic calcium ion transport | 2.010514e-3 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 2.058092e-3 |
GO:0046689 | response to mercury ion | 2.069939e-3 |
GO:0042116 | macrophage activation | 2.069939e-3 |
GO:0009066 | aspartate family amino acid metabolic process | 2.150598e-3 |
GO:0060712 | spongiotrophoblast layer development | 2.154062e-3 |
GO:0042158 | lipoprotein biosynthetic process | 2.176074e-3 |
GO:0060306 | regulation of membrane repolarization | 2.243393e-3 |
GO:0071379 | cellular response to prostaglandin stimulus | 2.287539e-3 |
GO:2000096 | positive regulation of Wnt receptor signaling pathway, planar cell polarity pathway | 2.295224e-3 |
GO:0035813 | regulation of renal sodium excretion | 2.325783e-3 |
GO:0006772 | thiamine metabolic process | 2.332217e-3 |
GO:0002064 | epithelial cell development | 2.332300e-3 |
GO:0048388 | endosomal lumen acidification | 2.344204e-3 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 2.344204e-3 |
GO:0007210 | serotonin receptor signaling pathway | 2.392896e-3 |
GO:0019896 | axon transport of mitochondrion | 2.442685e-3 |
GO:0016925 | protein sumoylation | 2.450554e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 2.461243e-3 |
GO:0042159 | lipoprotein catabolic process | 2.472546e-3 |
GO:0060118 | vestibular receptor cell development | 2.571272e-3 |
GO:0030704 | vitelline membrane formation | 2.571272e-3 |
GO:0014827 | intestine smooth muscle contraction | 2.644247e-3 |
GO:0010106 | cellular response to iron ion starvation | 2.698238e-3 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 2.721922e-3 |
GO:0031989 | bombesin receptor signaling pathway | 2.745513e-3 |
GO:0045346 | regulation of MHC class II biosynthetic process | 2.866868e-3 |
GO:0035166 | post-embryonic hemopoiesis | 2.894848e-3 |
GO:0061028 | establishment of endothelial barrier | 3.026613e-3 |
GO:0043555 | regulation of translation in response to stress | 3.078293e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 3.097845e-3 |
GO:0071702 | organic substance transport | 3.106665e-3 |
GO:0050884 | neuromuscular process controlling posture | 3.128681e-3 |
GO:2000344 | positive regulation of acrosome reaction | 3.158930e-3 |
GO:0034379 | very-low-density lipoprotein particle assembly | 3.159852e-3 |
GO:0007252 | I-kappaB phosphorylation | 3.176378e-3 |
GO:0018065 | protein-cofactor linkage | 3.193469e-3 |
GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 3.249512e-3 |
GO:0002070 | epithelial cell maturation | 3.282352e-3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.311272e-3 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 3.328894e-3 |
GO:0045773 | positive regulation of axon extension | 3.372858e-3 |
GO:0042559 | pteridine-containing compound biosynthetic process | 3.390854e-3 |
GO:0072531 | pyrimidine-containing compound transmembrane transport | 3.418955e-3 |
GO:0001514 | selenocysteine incorporation | 3.432502e-3 |
GO:0031952 | regulation of protein autophosphorylation | 3.442252e-3 |
GO:0007631 | feeding behavior | 3.450336e-3 |
GO:0006029 | proteoglycan metabolic process | 3.495972e-3 |
GO:0071705 | nitrogen compound transport | 3.535729e-3 |
GO:0007062 | sister chromatid cohesion | 3.545883e-3 |
GO:0035803 | egg coat formation | 3.562068e-3 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 3.603580e-3 |
GO:0031642 | negative regulation of myelination | 3.608527e-3 |
GO:0031953 | negative regulation of protein autophosphorylation | 3.621107e-3 |
GO:0021527 | spinal cord association neuron differentiation | 3.693122e-3 |
GO:0019433 | triglyceride catabolic process | 3.697926e-3 |
GO:0006662 | glycerol ether metabolic process | 3.737929e-3 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 3.761066e-3 |
GO:0060464 | lung lobe formation | 3.817078e-3 |
GO:0046588 | negative regulation of calcium-dependent cell-cell adhesion | 3.817078e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 3.852067e-3 |
GO:0009187 | cyclic nucleotide metabolic process | 3.878864e-3 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 3.959401e-3 |
GO:0033590 | response to cobalamin | 3.959401e-3 |
GO:0003290 | atrial septum secundum morphogenesis | 3.959401e-3 |
GO:0006117 | acetaldehyde metabolic process | 3.959401e-3 |
GO:0072321 | chaperone-mediated protein transport | 3.989467e-3 |
GO:0045687 | positive regulation of glial cell differentiation | 4.016836e-3 |
GO:0048312 | intracellular distribution of mitochondria | 4.130653e-3 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 4.130653e-3 |
GO:0051647 | nucleus localization | 4.132086e-3 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 4.186939e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 4.186939e-3 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 4.186939e-3 |
GO:0045947 | negative regulation of translational initiation | 4.336396e-3 |
GO:0031497 | chromatin assembly | 4.343540e-3 |
GO:0000186 | activation of MAPKK activity | 4.419831e-3 |
GO:0016226 | iron-sulfur cluster assembly | 4.530866e-3 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 4.532754e-3 |
GO:0032497 | detection of lipopolysaccharide | 4.581120e-3 |
GO:0060539 | diaphragm development | 4.618995e-3 |
GO:0040023 | establishment of nucleus localization | 4.640992e-3 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 4.697110e-3 |
GO:0045446 | endothelial cell differentiation | 4.699572e-3 |
GO:0060575 | intestinal epithelial cell differentiation | 4.725964e-3 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 4.730725e-3 |
GO:0008216 | spermidine metabolic process | 4.730725e-3 |
GO:0015879 | carnitine transport | 4.753202e-3 |
GO:0045472 | response to ether | 4.783217e-3 |
GO:0019230 | proprioception | 4.818946e-3 |
GO:0046475 | glycerophospholipid catabolic process | 4.836472e-3 |
GO:0006467 | protein thiol-disulfide exchange | 4.867919e-3 |
GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway | 4.874287e-3 |
GO:0031223 | auditory behavior | 4.948792e-3 |
GO:0010884 | positive regulation of lipid storage | 5.168676e-3 |
GO:0006813 | potassium ion transport | 5.199893e-3 |
GO:0030157 | pancreatic juice secretion | 5.204986e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 5.274322e-3 |
GO:0030855 | epithelial cell differentiation | 5.307807e-3 |
GO:0032647 | regulation of interferon-alpha production | 5.334308e-3 |
GO:0035815 | positive regulation of renal sodium excretion | 5.334308e-3 |
GO:0060968 | regulation of gene silencing | 5.339596e-3 |
GO:0031114 | regulation of microtubule depolymerization | 5.381358e-3 |
GO:0009595 | detection of biotic stimulus | 5.423308e-3 |
GO:0044242 | cellular lipid catabolic process | 5.490291e-3 |
GO:0090331 | negative regulation of platelet aggregation | 5.527760e-3 |
GO:0061110 | dense core granule biogenesis | 5.527760e-3 |
GO:0042628 | mating plug formation | 5.527760e-3 |
GO:0061108 | seminal vesicle epithelium development | 5.527760e-3 |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 5.530298e-3 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 5.620791e-3 |
GO:0061162 | establishment of monopolar cell polarity | 5.626055e-3 |
GO:0070207 | protein homotrimerization | 5.752551e-3 |
GO:0051099 | positive regulation of binding | 5.753057e-3 |
GO:0045540 | regulation of cholesterol biosynthetic process | 5.757532e-3 |
GO:0052565 | response to defense-related host nitric oxide production | 5.789420e-3 |
GO:0030844 | positive regulation of intermediate filament depolymerization | 5.789420e-3 |
GO:0007097 | nuclear migration | 5.832314e-3 |
GO:0009649 | entrainment of circadian clock | 5.875719e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 5.930866e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 5.959094e-3 |
GO:0010876 | lipid localization | 6.153379e-3 |
GO:0015791 | polyol transport | 6.173054e-3 |
GO:0007026 | negative regulation of microtubule depolymerization | 6.220145e-3 |
GO:0071104 | response to interleukin-9 | 6.256698e-3 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 6.256698e-3 |
GO:0033292 | T-tubule organization | 6.256698e-3 |
GO:0060096 | serotonin secretion, neurotransmission | 6.256698e-3 |
GO:0060299 | negative regulation of sarcomere organization | 6.256698e-3 |
GO:0061205 | paramesonephric duct development | 6.311773e-3 |
GO:0032928 | regulation of superoxide anion generation | 6.383088e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 6.457816e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 6.466884e-3 |
GO:0003184 | pulmonary valve morphogenesis | 6.466884e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 6.466884e-3 |
GO:0044089 | positive regulation of cellular component biogenesis | 6.574529e-3 |
GO:0031557 | induction of programmed cell death in response to chemical stimulus | 6.626170e-3 |
GO:0060662 | salivary gland cavitation | 6.784513e-3 |
GO:0032006 | regulation of TOR signaling cascade | 6.830348e-3 |
GO:0034728 | nucleosome organization | 6.840558e-3 |
GO:0007007 | inner mitochondrial membrane organization | 6.871834e-3 |
GO:0060402 | calcium ion transport into cytosol | 6.942524e-3 |
GO:0001885 | endothelial cell development | 7.039359e-3 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 7.101814e-3 |
GO:0006706 | steroid catabolic process | 7.127888e-3 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 7.175615e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 7.243254e-3 |
GO:0031427 | response to methotrexate | 7.513403e-3 |
GO:0032799 | low-density lipoprotein receptor particle metabolic process | 7.513403e-3 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 7.513403e-3 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 7.562143e-3 |
GO:0045792 | negative regulation of cell size | 7.731573e-3 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 7.780023e-3 |
GO:0030490 | maturation of SSU-rRNA | 7.826597e-3 |
GO:0046477 | glycosylceramide catabolic process | 7.826597e-3 |
GO:0051028 | mRNA transport | 7.851415e-3 |
GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 7.890461e-3 |
GO:0042255 | ribosome assembly | 7.933574e-3 |
GO:0046039 | GTP metabolic process | 7.950828e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 8.002903e-3 |
GO:0046464 | acylglycerol catabolic process | 8.375903e-3 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 8.434440e-3 |
GO:0019255 | glucose 1-phosphate metabolic process | 8.434440e-3 |
GO:0060482 | lobar bronchus development | 8.434440e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 8.572736e-3 |
GO:0071827 | plasma lipoprotein particle organization | 8.675482e-3 |
GO:0014015 | positive regulation of gliogenesis | 8.806646e-3 |
GO:0010572 | positive regulation of platelet activation | 8.876000e-3 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 8.896771e-3 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 8.973667e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 8.973667e-3 |
GO:0000920 | cytokinetic cell separation | 8.973667e-3 |
GO:0008206 | bile acid metabolic process | 9.027403e-3 |
GO:0032781 | positive regulation of ATPase activity | 9.050261e-3 |
GO:0042420 | dopamine catabolic process | 9.070691e-3 |
GO:0006542 | glutamine biosynthetic process | 9.184933e-3 |
GO:0006612 | protein targeting to membrane | 9.226951e-3 |
GO:0042977 | activation of JAK2 kinase activity | 9.262890e-3 |
GO:0042305 | specification of segmental identity, mandibular segment | 9.290409e-3 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 9.290409e-3 |
GO:0018184 | protein polyamination | 9.290409e-3 |
GO:0048678 | response to axon injury | 9.296975e-3 |
GO:0006739 | NADP metabolic process | 9.370479e-3 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 9.521346e-3 |
GO:0060711 | labyrinthine layer development | 9.537681e-3 |
GO:0018209 | peptidyl-serine modification | 9.555511e-3 |
GO:2000052 | positive regulation of non-canonical Wnt receptor signaling pathway | 9.592155e-3 |
GO:0043585 | nose morphogenesis | 9.592155e-3 |
GO:0030308 | negative regulation of cell growth | 9.593676e-3 |
GO:0030317 | sperm motility | 9.604014e-3 |
GO:0070671 | response to interleukin-12 | 9.741456e-3 |
GO:0002066 | columnar/cuboidal epithelial cell development | 9.821674e-3 |
GO:0042274 | ribosomal small subunit biogenesis | 9.933439e-3 |
GO:0006848 | pyruvate transport | 9.946947e-3 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 9.946947e-3 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 9.946947e-3 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 9.946947e-3 |
GO:0031648 | protein destabilization | 1.005558e-2 |
GO:0051320 | S phase | 1.008017e-2 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 1.015134e-2 |
GO:0015810 | aspartate transport | 1.026278e-2 |
GO:0061156 | pulmonary artery morphogenesis | 1.029235e-2 |
GO:0071360 | cellular response to exogenous dsRNA | 1.035196e-2 |
GO:0050999 | regulation of nitric-oxide synthase activity | 1.041693e-2 |
GO:0060708 | spongiotrophoblast differentiation | 1.045447e-2 |
GO:0006403 | RNA localization | 1.067208e-2 |
GO:0006184 | GTP catabolic process | 1.078802e-2 |
GO:0050651 | dermatan sulfate proteoglycan biosynthetic process | 1.083826e-2 |
GO:0046330 | positive regulation of JNK cascade | 1.089715e-2 |
GO:0014056 | regulation of acetylcholine secretion | 1.099496e-2 |
GO:0070483 | detection of hypoxia | 1.099496e-2 |
GO:0045343 | regulation of MHC class I biosynthetic process | 1.104322e-2 |
GO:0007064 | mitotic sister chromatid cohesion | 1.106484e-2 |
GO:0008078 | mesodermal cell migration | 1.110234e-2 |
GO:0048844 | artery morphogenesis | 1.118617e-2 |
GO:0030149 | sphingolipid catabolic process | 1.126541e-2 |
GO:0010761 | fibroblast migration | 1.126541e-2 |
GO:0060765 | regulation of androgen receptor signaling pathway | 1.127125e-2 |
GO:0034764 | positive regulation of transmembrane transport | 1.140855e-2 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 1.166946e-2 |
GO:0046328 | regulation of JNK cascade | 1.175966e-2 |
GO:0051100 | negative regulation of binding | 1.196785e-2 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.197401e-2 |
GO:0007638 | mechanosensory behavior | 1.200083e-2 |
GO:0048563 | post-embryonic organ morphogenesis | 1.200914e-2 |
GO:0015801 | aromatic amino acid transport | 1.200914e-2 |
GO:0046113 | nucleobase catabolic process | 1.205947e-2 |
GO:0001937 | negative regulation of endothelial cell proliferation | 1.215221e-2 |
GO:0060046 | regulation of acrosome reaction | 1.217757e-2 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 1.226225e-2 |
GO:0003158 | endothelium development | 1.227318e-2 |
GO:0032008 | positive regulation of TOR signaling cascade | 1.233334e-2 |
GO:0006983 | ER overload response | 1.244433e-2 |
GO:0007597 | blood coagulation, intrinsic pathway | 1.257403e-2 |
GO:0051668 | localization within membrane | 1.259798e-2 |
GO:0007218 | neuropeptide signaling pathway | 1.259934e-2 |
GO:0050658 | RNA transport | 1.262827e-2 |
GO:0032757 | positive regulation of interleukin-8 production | 1.265037e-2 |
GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway | 1.270780e-2 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 1.270780e-2 |
GO:0051701 | interaction with host | 1.279772e-2 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 1.285351e-2 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.285351e-2 |
GO:0006177 | GMP biosynthetic process | 1.285351e-2 |
GO:0051657 | maintenance of organelle location | 1.292270e-2 |
GO:0006835 | dicarboxylic acid transport | 1.299989e-2 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.311892e-2 |
GO:0030206 | chondroitin sulfate biosynthetic process | 1.313488e-2 |
GO:0060535 | trachea cartilage morphogenesis | 1.320226e-2 |
GO:0048639 | positive regulation of developmental growth | 1.324289e-2 |
GO:0032092 | positive regulation of protein binding | 1.345552e-2 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 1.372154e-2 |
GO:0010713 | negative regulation of collagen metabolic process | 1.372154e-2 |
GO:0046549 | retinal cone cell development | 1.372872e-2 |
GO:0050655 | dermatan sulfate proteoglycan metabolic process | 1.372872e-2 |
GO:0006555 | methionine metabolic process | 1.378235e-2 |
GO:0022614 | membrane to membrane docking | 1.383734e-2 |
GO:2000095 | regulation of Wnt receptor signaling pathway, planar cell polarity pathway | 1.386080e-2 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 1.401124e-2 |
GO:0046503 | glycerolipid catabolic process | 1.429090e-2 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 1.429247e-2 |
GO:0014057 | positive regulation of acetylcholine secretion | 1.429247e-2 |
GO:0006412 | translation | 1.431914e-2 |
GO:0071243 | cellular response to arsenic-containing substance | 1.435625e-2 |
GO:0051712 | positive regulation of killing of cells of other organism | 1.435625e-2 |
GO:0060998 | regulation of dendritic spine development | 1.437014e-2 |
GO:0051205 | protein insertion into membrane | 1.444005e-2 |
GO:0007416 | synapse assembly | 1.481847e-2 |
GO:0031123 | RNA 3'-end processing | 1.484166e-2 |
GO:0090322 | regulation of superoxide metabolic process | 1.504304e-2 |
GO:0046795 | intracellular virion transport | 1.505485e-2 |
GO:0046341 | CDP-diacylglycerol metabolic process | 1.505485e-2 |
GO:0006164 | purine nucleotide biosynthetic process | 1.507271e-2 |
GO:0032633 | interleukin-4 production | 1.509016e-2 |
GO:0001865 | NK T cell differentiation | 1.509016e-2 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.558293e-2 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 1.558293e-2 |
GO:0051098 | regulation of binding | 1.564512e-2 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 1.568106e-2 |
GO:0032496 | response to lipopolysaccharide | 1.573920e-2 |
GO:0030203 | glycosaminoglycan metabolic process | 1.574003e-2 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 1.579253e-2 |
GO:0033326 | cerebrospinal fluid secretion | 1.584274e-2 |
GO:0008203 | cholesterol metabolic process | 1.591733e-2 |
GO:0006865 | amino acid transport | 1.591733e-2 |
GO:0051480 | cytosolic calcium ion homeostasis | 1.592736e-2 |
GO:0042558 | pteridine-containing compound metabolic process | 1.601497e-2 |
GO:0070212 | protein poly-ADP-ribosylation | 1.601630e-2 |
GO:0043393 | regulation of protein binding | 1.615502e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048240 | sperm capacitation | 1.603861e-13 |
GO:0060074 | synapse maturation | 6.365769e-9 |
GO:0010722 | regulation of ferrochelatase activity | 1.359664e-8 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.953500e-8 |
GO:0010872 | regulation of cholesterol esterification | 3.442389e-8 |
GO:0010873 | positive regulation of cholesterol esterification | 4.246618e-8 |
GO:0060971 | embryonic heart tube left/right pattern formation | 1.528670e-7 |
GO:0007258 | JUN phosphorylation | 1.905140e-7 |
GO:0045210 | FasL biosynthetic process | 3.120332e-7 |
GO:0032765 | positive regulation of mast cell cytokine production | 3.120332e-7 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 3.120332e-7 |
GO:0007254 | JNK cascade | 4.329923e-7 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 5.944495e-7 |
GO:0031098 | stress-activated protein kinase signaling cascade | 7.252970e-7 |
GO:0070286 | axonemal dynein complex assembly | 1.523891e-6 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 1.638170e-6 |
GO:0016540 | protein autoprocessing | 2.082320e-6 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 2.282429e-6 |
GO:0001805 | positive regulation of type III hypersensitivity | 4.231432e-6 |
GO:0019230 | proprioception | 4.945292e-6 |
GO:0045963 | negative regulation of dopamine metabolic process | 5.583484e-6 |
GO:0050668 | positive regulation of homocysteine metabolic process | 5.583484e-6 |
GO:0007586 | digestion | 5.906968e-6 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 7.006798e-6 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 7.376614e-6 |
GO:0007286 | spermatid development | 8.388427e-6 |
GO:2000781 | positive regulation of double-strand break repair | 8.493952e-6 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 8.677865e-6 |
GO:0071071 | regulation of phospholipid biosynthetic process | 9.698921e-6 |
GO:0043129 | surfactant homeostasis | 1.213236e-5 |
GO:0071214 | cellular response to abiotic stimulus | 1.272974e-5 |
GO:0000302 | response to reactive oxygen species | 1.363495e-5 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 1.735718e-5 |
GO:0060928 | atrioventricular node cell development | 2.164164e-5 |
GO:0060929 | atrioventricular node cell fate commitment | 2.164164e-5 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 2.164164e-5 |
GO:0015739 | sialic acid transport | 2.164164e-5 |
GO:0006258 | UDP-glucose catabolic process | 2.164164e-5 |
GO:0003342 | proepicardium development | 2.164164e-5 |
GO:0006011 | UDP-glucose metabolic process | 2.393402e-5 |
GO:0043691 | reverse cholesterol transport | 2.591787e-5 |
GO:0070482 | response to oxygen levels | 2.673928e-5 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 2.827663e-5 |
GO:0001812 | positive regulation of type I hypersensitivity | 3.231756e-5 |
GO:0006783 | heme biosynthetic process | 3.515303e-5 |
GO:0030149 | sphingolipid catabolic process | 3.668889e-5 |
GO:0006611 | protein export from nucleus | 4.015040e-5 |
GO:0034599 | cellular response to oxidative stress | 4.062683e-5 |
GO:0007501 | mesodermal cell fate specification | 4.205907e-5 |
GO:0046466 | membrane lipid catabolic process | 4.216725e-5 |
GO:0046148 | pigment biosynthetic process | 4.701682e-5 |
GO:0048554 | positive regulation of metalloenzyme activity | 4.718466e-5 |
GO:0018364 | peptidyl-glutamine methylation | 4.902864e-5 |
GO:0051176 | positive regulation of sulfur metabolic process | 6.023856e-5 |
GO:0001666 | response to hypoxia | 6.234103e-5 |
GO:0000305 | response to oxygen radical | 6.860862e-5 |
GO:0042053 | regulation of dopamine metabolic process | 7.358922e-5 |
GO:0060620 | regulation of cholesterol import | 8.170741e-5 |
GO:0003029 | detection of hypoxic conditions in blood by carotid body chemoreceptor signaling | 8.892186e-5 |
GO:0014074 | response to purine-containing compound | 9.168994e-5 |
GO:0030300 | regulation of intestinal cholesterol absorption | 1.036832e-4 |
GO:0032049 | cardiolipin biosynthetic process | 1.057714e-4 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.057714e-4 |
GO:0042742 | defense response to bacterium | 1.162416e-4 |
GO:0065005 | protein-lipid complex assembly | 1.174593e-4 |
GO:0060695 | negative regulation of cholesterol transporter activity | 1.191090e-4 |
GO:0060480 | lung goblet cell differentiation | 1.191090e-4 |
GO:0015759 | beta-glucoside transport | 1.191090e-4 |
GO:0055072 | iron ion homeostasis | 1.244543e-4 |
GO:0051865 | protein autoubiquitination | 1.273042e-4 |
GO:0031000 | response to caffeine | 1.318931e-4 |
GO:0008356 | asymmetric cell division | 1.436824e-4 |
GO:0060574 | intestinal epithelial cell maturation | 1.557919e-4 |
GO:0042069 | regulation of catecholamine metabolic process | 1.662293e-4 |
GO:0048515 | spermatid differentiation | 1.677680e-4 |
GO:0002385 | mucosal immune response | 1.734767e-4 |
GO:0072592 | oxygen metabolic process | 1.757105e-4 |
GO:0038007 | netrin-activated signaling pathway | 1.765836e-4 |
GO:0006621 | protein retention in ER lumen | 1.834659e-4 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 1.888330e-4 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 1.904481e-4 |
GO:0070318 | positive regulation of G0 to G1 transition | 1.957785e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 1.957785e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 1.957785e-4 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 2.038010e-4 |
GO:0021604 | cranial nerve structural organization | 2.179731e-4 |
GO:0006188 | IMP biosynthetic process | 2.244078e-4 |
GO:0001810 | regulation of type I hypersensitivity | 2.244078e-4 |
GO:0034508 | centromere complex assembly | 2.335716e-4 |
GO:0051341 | regulation of oxidoreductase activity | 2.343112e-4 |
GO:0071034 | CUT catabolic process | 2.515987e-4 |
GO:0043312 | neutrophil degranulation | 2.515987e-4 |
GO:0051382 | kinetochore assembly | 2.515987e-4 |
GO:0002251 | organ or tissue specific immune response | 2.616650e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 2.820564e-4 |
GO:0032048 | cardiolipin metabolic process | 2.823428e-4 |
GO:0046835 | carbohydrate phosphorylation | 2.830627e-4 |
GO:0033005 | positive regulation of mast cell activation | 2.868770e-4 |
GO:0046129 | purine ribonucleoside biosynthetic process | 2.890064e-4 |
GO:0051168 | nuclear export | 3.226550e-4 |
GO:0007281 | germ cell development | 3.444083e-4 |
GO:0046033 | AMP metabolic process | 3.459219e-4 |
GO:0072384 | organelle transport along microtubule | 3.497590e-4 |
GO:0042946 | glucoside transport | 3.510436e-4 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 3.510436e-4 |
GO:0060576 | intestinal epithelial cell development | 3.899888e-4 |
GO:0071478 | cellular response to radiation | 3.947038e-4 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 3.964203e-4 |
GO:0006855 | drug transmembrane transport | 3.975819e-4 |
GO:0050798 | activated T cell proliferation | 4.144745e-4 |
GO:0033026 | negative regulation of mast cell apoptosis | 4.348759e-4 |
GO:0042135 | neurotransmitter catabolic process | 4.418174e-4 |
GO:0006707 | cholesterol catabolic process | 4.418174e-4 |
GO:0042168 | heme metabolic process | 4.623522e-4 |
GO:0034435 | cholesterol esterification | 4.652476e-4 |
GO:0072661 | protein targeting to plasma membrane | 4.787718e-4 |
GO:0042398 | cellular modified amino acid biosynthetic process | 5.000383e-4 |
GO:0033554 | cellular response to stress | 5.127094e-4 |
GO:0016558 | protein import into peroxisome matrix | 5.315066e-4 |
GO:0070316 | regulation of G0 to G1 transition | 5.544116e-4 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 5.562950e-4 |
GO:0090045 | positive regulation of deacetylase activity | 5.894156e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 5.894156e-4 |
GO:0008615 | pyridoxine biosynthetic process | 5.894156e-4 |
GO:0003026 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback | 5.920587e-4 |
GO:0002542 | Factor XII activation | 5.920587e-4 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.200298e-4 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 6.322205e-4 |
GO:0051262 | protein tetramerization | 6.363190e-4 |
GO:0030970 | retrograde protein transport, ER to cytosol | 6.399492e-4 |
GO:0042420 | dopamine catabolic process | 6.482735e-4 |
GO:0022600 | digestive system process | 6.588354e-4 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 6.589647e-4 |
GO:0043620 | regulation of DNA-dependent transcription in response to stress | 6.888142e-4 |
GO:0006979 | response to oxidative stress | 7.851723e-4 |
GO:0042440 | pigment metabolic process | 7.921373e-4 |
GO:0048532 | anatomical structure arrangement | 7.994814e-4 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 8.033953e-4 |
GO:0046086 | adenosine biosynthetic process | 8.374057e-4 |
GO:0010045 | response to nickel ion | 8.374057e-4 |
GO:0006196 | AMP catabolic process | 8.374057e-4 |
GO:0051383 | kinetochore organization | 8.401573e-4 |
GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway | 8.451274e-4 |
GO:0019452 | L-cysteine catabolic process to taurine | 8.451274e-4 |
GO:0003278 | apoptosis involved in heart morphogenesis | 8.451274e-4 |
GO:0002885 | positive regulation of hypersensitivity | 8.860134e-4 |
GO:0060621 | negative regulation of cholesterol import | 9.107490e-4 |
GO:0010035 | response to inorganic substance | 9.468571e-4 |
GO:0032909 | regulation of transforming growth factor beta2 production | 1.008710e-3 |
GO:0021629 | olfactory nerve structural organization | 1.085365e-3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.085365e-3 |
GO:0001710 | mesodermal cell fate commitment | 1.100057e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 1.102583e-3 |
GO:0033025 | regulation of mast cell apoptosis | 1.118992e-3 |
GO:0042149 | cellular response to glucose starvation | 1.204795e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 1.252753e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.252753e-3 |
GO:0002540 | leukotriene production involved in inflammatory response | 1.254343e-3 |
GO:0071285 | cellular response to lithium ion | 1.255826e-3 |
GO:0055085 | transmembrane transport | 1.256278e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 1.305514e-3 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 1.381893e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 1.398673e-3 |
GO:0050770 | regulation of axonogenesis | 1.421861e-3 |
GO:0009113 | purine base biosynthetic process | 1.429624e-3 |
GO:0006982 | response to lipid hydroperoxide | 1.429624e-3 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 1.492799e-3 |
GO:0015893 | drug transport | 1.527326e-3 |
GO:0001977 | renal system process involved in regulation of blood volume | 1.527424e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 1.561283e-3 |
GO:0051353 | positive regulation of oxidoreductase activity | 1.604539e-3 |
GO:0070170 | regulation of tooth mineralization | 1.621044e-3 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 1.647581e-3 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 1.649829e-3 |
GO:0071248 | cellular response to metal ion | 1.674910e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 1.681374e-3 |
GO:0031334 | positive regulation of protein complex assembly | 1.715764e-3 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 1.728557e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 1.736382e-3 |
GO:0047497 | mitochondrion transport along microtubule | 1.807772e-3 |
GO:0042424 | catecholamine catabolic process | 1.829008e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 1.835567e-3 |
GO:0046434 | organophosphate catabolic process | 1.936984e-3 |
GO:0006625 | protein targeting to peroxisome | 1.956499e-3 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 2.011025e-3 |
GO:0070979 | protein K11-linked ubiquitination | 2.066135e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 2.068008e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 2.106934e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 2.119784e-3 |
GO:0032287 | peripheral nervous system myelin maintenance | 2.131654e-3 |
GO:2000017 | positive regulation of determination of dorsal identity | 2.155744e-3 |
GO:0034614 | cellular response to reactive oxygen species | 2.164697e-3 |
GO:0051668 | localization within membrane | 2.194667e-3 |
GO:0035020 | regulation of Rac protein signal transduction | 2.205259e-3 |
GO:0001525 | angiogenesis | 2.239199e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 2.333297e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 2.333297e-3 |
GO:0010823 | negative regulation of mitochondrion organization | 2.340932e-3 |
GO:0009119 | ribonucleoside metabolic process | 2.346805e-3 |
GO:0071482 | cellular response to light stimulus | 2.406159e-3 |
GO:0051646 | mitochondrion localization | 2.425766e-3 |
GO:0042402 | cellular biogenic amine catabolic process | 2.465097e-3 |
GO:0046898 | response to cycloheximide | 2.472273e-3 |
GO:0045333 | cellular respiration | 2.505108e-3 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 2.507850e-3 |
GO:0016338 | calcium-independent cell-cell adhesion | 2.508683e-3 |
GO:0046112 | nucleobase biosynthetic process | 2.510384e-3 |
GO:0045739 | positive regulation of DNA repair | 2.629431e-3 |
GO:0048133 | male germ-line stem cell division | 2.647128e-3 |
GO:0071277 | cellular response to calcium ion | 2.649186e-3 |
GO:0060435 | bronchiole development | 2.684079e-3 |
GO:0060335 | positive regulation of interferon-gamma-mediated signaling pathway | 2.734037e-3 |
GO:0033128 | negative regulation of histone phosphorylation | 2.734037e-3 |
GO:0006012 | galactose metabolic process | 2.839680e-3 |
GO:0043043 | peptide biosynthetic process | 2.851289e-3 |
GO:0090187 | positive regulation of pancreatic juice secretion | 2.876190e-3 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 2.876190e-3 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 2.876190e-3 |
GO:0031118 | rRNA pseudouridine synthesis | 2.876190e-3 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 2.876190e-3 |
GO:0048013 | ephrin receptor signaling pathway | 2.884989e-3 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 2.888917e-3 |
GO:0060217 | hemangioblast cell differentiation | 2.888917e-3 |
GO:0046038 | GMP catabolic process | 2.888917e-3 |
GO:0032264 | IMP salvage | 2.888917e-3 |
GO:0006178 | guanine salvage | 2.888917e-3 |
GO:0032263 | GMP salvage | 2.888917e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 2.933891e-3 |
GO:0031659 | positive regulation of cyclin-dependent protein kinase activity involved in G1/S | 2.939676e-3 |
GO:0002318 | myeloid progenitor cell differentiation | 2.939676e-3 |
GO:0006493 | protein O-linked glycosylation | 2.999542e-3 |
GO:0021895 | cerebral cortex neuron differentiation | 3.031121e-3 |
GO:0006661 | phosphatidylinositol biosynthetic process | 3.088278e-3 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 3.168565e-3 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 3.216650e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.244172e-3 |
GO:0016042 | lipid catabolic process | 3.263511e-3 |
GO:0043217 | myelin maintenance | 3.277215e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 3.277215e-3 |
GO:0070995 | NADPH oxidation | 3.280162e-3 |
GO:0010226 | response to lithium ion | 3.387353e-3 |
GO:0035634 | response to stilbenoid | 3.440076e-3 |
GO:0006879 | cellular iron ion homeostasis | 3.472906e-3 |
GO:0006168 | adenine salvage | 3.485792e-3 |
GO:0023021 | termination of signal transduction | 3.695677e-3 |
GO:0051541 | elastin metabolic process | 3.754044e-3 |
GO:0045646 | regulation of erythrocyte differentiation | 3.772312e-3 |
GO:0046128 | purine ribonucleoside metabolic process | 3.782828e-3 |
GO:0051654 | establishment of mitochondrion localization | 3.814483e-3 |
GO:0046709 | IDP catabolic process | 3.875445e-3 |
GO:0046032 | ADP catabolic process | 3.875445e-3 |
GO:0006177 | GMP biosynthetic process | 3.875445e-3 |
GO:0071241 | cellular response to inorganic substance | 3.881240e-3 |
GO:0032863 | activation of Rac GTPase activity | 3.948239e-3 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.948239e-3 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 3.966643e-3 |
GO:0015938 | coenzyme A catabolic process | 3.996694e-3 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 3.996694e-3 |
GO:0009589 | detection of UV | 3.996694e-3 |
GO:0006756 | AMP phosphorylation | 3.996694e-3 |
GO:0071456 | cellular response to hypoxia | 4.018652e-3 |
GO:0055090 | acylglycerol homeostasis | 4.021239e-3 |
GO:0051188 | cofactor biosynthetic process | 4.159450e-3 |
GO:0033194 | response to hydroperoxide | 4.266385e-3 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 4.298714e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 4.375118e-3 |
GO:0015936 | coenzyme A metabolic process | 4.470156e-3 |
GO:0032755 | positive regulation of interleukin-6 production | 4.497178e-3 |
GO:0006796 | phosphate-containing compound metabolic process | 4.525896e-3 |
GO:0050919 | negative chemotaxis | 4.571479e-3 |
GO:0070173 | regulation of enamel mineralization | 4.583646e-3 |
GO:0071335 | hair follicle cell proliferation | 4.583646e-3 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 4.583646e-3 |
GO:0032290 | peripheral nervous system myelin formation | 4.583646e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 4.583646e-3 |
GO:0046340 | diacylglycerol catabolic process | 4.627431e-3 |
GO:0010639 | negative regulation of organelle organization | 4.713312e-3 |
GO:0044058 | regulation of digestive system process | 4.715703e-3 |
GO:0044003 | modification by symbiont of host morphology or physiology | 4.818452e-3 |
GO:0090193 | positive regulation of glomerulus development | 4.858847e-3 |
GO:0009116 | nucleoside metabolic process | 4.865270e-3 |
GO:0009060 | aerobic respiration | 4.908875e-3 |
GO:0021502 | neural fold elevation formation | 4.973201e-3 |
GO:0015816 | glycine transport | 5.043308e-3 |
GO:0003093 | regulation of glomerular filtration | 5.043308e-3 |
GO:0008652 | cellular amino acid biosynthetic process | 5.076317e-3 |
GO:0051205 | protein insertion into membrane | 5.116561e-3 |
GO:0007256 | activation of JNKK activity | 5.227155e-3 |
GO:0006750 | glutathione biosynthetic process | 5.252822e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 5.277890e-3 |
GO:0050892 | intestinal absorption | 5.323026e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 5.359605e-3 |
GO:0006507 | GPI anchor release | 5.359605e-3 |
GO:0000147 | actin cortical patch assembly | 5.359605e-3 |
GO:0000303 | response to superoxide | 5.403322e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 5.412077e-3 |
GO:0006685 | sphingomyelin catabolic process | 5.414813e-3 |
GO:0001732 | formation of translation initiation complex | 5.481449e-3 |
GO:0032780 | negative regulation of ATPase activity | 5.481449e-3 |
GO:0080111 | DNA demethylation | 5.500662e-3 |
GO:0002227 | innate immune response in mucosa | 5.624448e-3 |
GO:0006166 | purine ribonucleoside salvage | 5.724189e-3 |
GO:0007566 | embryo implantation | 5.784668e-3 |
GO:0034622 | cellular macromolecular complex assembly | 5.822933e-3 |
GO:0003333 | amino acid transmembrane transport | 5.919375e-3 |
GO:0019228 | regulation of action potential in neuron | 5.958457e-3 |
GO:0021675 | nerve development | 6.010593e-3 |
GO:0002883 | regulation of hypersensitivity | 6.053922e-3 |
GO:0044243 | multicellular organismal catabolic process | 6.189261e-3 |
GO:0048014 | Tie receptor signaling pathway | 6.196708e-3 |
GO:0002066 | columnar/cuboidal epithelial cell development | 6.247289e-3 |
GO:0033522 | histone H2A ubiquitination | 6.454904e-3 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 6.556770e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 6.617437e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 6.617437e-3 |
GO:0032202 | telomere assembly | 6.617437e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 6.617437e-3 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 6.617437e-3 |
GO:0016226 | iron-sulfur cluster assembly | 6.664422e-3 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 6.812683e-3 |
GO:0033240 | positive regulation of cellular amine metabolic process | 6.812683e-3 |
GO:0035510 | DNA dealkylation | 6.812683e-3 |
GO:0032314 | regulation of Rac GTPase activity | 6.822811e-3 |
GO:0070988 | demethylation | 6.843543e-3 |
GO:0022613 | ribonucleoprotein complex biogenesis | 6.923462e-3 |
GO:0060972 | left/right pattern formation | 6.940499e-3 |
GO:0071415 | cellular response to purine-containing compound | 7.001234e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 7.001234e-3 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 7.001234e-3 |
GO:0010756 | positive regulation of plasminogen activation | 7.042291e-3 |
GO:0071542 | dopaminergic neuron differentiation | 7.313552e-3 |
GO:0045213 | neurotransmitter receptor metabolic process | 7.332323e-3 |
GO:0070838 | divalent metal ion transport | 7.362550e-3 |
GO:0000165 | MAPKKK cascade | 7.447838e-3 |
GO:0070257 | positive regulation of mucus secretion | 7.476057e-3 |
GO:0072511 | divalent inorganic cation transport | 7.583867e-3 |
GO:0060754 | positive regulation of mast cell chemotaxis | 7.680942e-3 |
GO:0045576 | mast cell activation | 7.934536e-3 |
GO:0051973 | positive regulation of telomerase activity | 7.995212e-3 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 7.995212e-3 |
GO:0009253 | peptidoglycan catabolic process | 7.995212e-3 |
GO:0070189 | kynurenine metabolic process | 8.010424e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 8.010424e-3 |
GO:0071453 | cellular response to oxygen levels | 8.211554e-3 |
GO:0010039 | response to iron ion | 8.243952e-3 |
GO:0071722 | detoxification of arsenic-containing substance | 8.320140e-3 |
GO:0002176 | male germ cell proliferation | 8.320140e-3 |
GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep | 8.320140e-3 |
GO:0032928 | regulation of superoxide anion generation | 8.480061e-3 |
GO:0019695 | choline metabolic process | 8.553634e-3 |
GO:0003407 | neural retina development | 8.569774e-3 |
GO:0014020 | primary neural tube formation | 8.658602e-3 |
GO:0002426 | immunoglobulin production in mucosal tissue | 8.704233e-3 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 8.731708e-3 |
GO:0060612 | adipose tissue development | 8.744714e-3 |
GO:0046514 | ceramide catabolic process | 8.751142e-3 |
GO:0034377 | plasma lipoprotein particle assembly | 8.839790e-3 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 8.943266e-3 |
GO:0045964 | positive regulation of dopamine metabolic process | 8.943266e-3 |
GO:0010312 | detoxification of zinc ion | 8.943266e-3 |
GO:0045836 | positive regulation of meiosis | 8.954436e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 9.103522e-3 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 9.204869e-3 |
GO:0008202 | steroid metabolic process | 9.327256e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 9.475246e-3 |
GO:0046621 | negative regulation of organ growth | 9.543486e-3 |
GO:0061088 | regulation of sequestering of zinc ion | 9.559919e-3 |
GO:0007565 | female pregnancy | 9.635413e-3 |
GO:0045065 | cytotoxic T cell differentiation | 9.688376e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 9.913681e-3 |
GO:0070574 | cadmium ion transmembrane transport | 1.006948e-2 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 1.006948e-2 |
GO:0045773 | positive regulation of axon extension | 1.007591e-2 |
GO:0022011 | myelination in peripheral nervous system | 1.014996e-2 |
GO:0009746 | response to hexose stimulus | 1.017023e-2 |
GO:0001547 | antral ovarian follicle growth | 1.026561e-2 |
GO:0021602 | cranial nerve morphogenesis | 1.059108e-2 |
GO:0006406 | mRNA export from nucleus | 1.061029e-2 |
GO:0021545 | cranial nerve development | 1.064880e-2 |
GO:0006413 | translational initiation | 1.064880e-2 |
GO:0070837 | dehydroascorbic acid transport | 1.075283e-2 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 1.075327e-2 |
GO:0006942 | regulation of striated muscle contraction | 1.079641e-2 |
GO:0051026 | chiasma assembly | 1.080511e-2 |
GO:0009411 | response to UV | 1.082324e-2 |
GO:0044241 | lipid digestion | 1.101479e-2 |
GO:0050772 | positive regulation of axonogenesis | 1.101586e-2 |
GO:0015980 | energy derivation by oxidation of organic compounds | 1.103071e-2 |
GO:0009749 | response to glucose stimulus | 1.104390e-2 |
GO:0050872 | white fat cell differentiation | 1.109717e-2 |
GO:0035121 | tail morphogenesis | 1.111241e-2 |
GO:0007032 | endosome organization | 1.111241e-2 |
GO:0071479 | cellular response to ionizing radiation | 1.116247e-2 |
GO:0050830 | defense response to Gram-positive bacterium | 1.118501e-2 |
GO:0008089 | anterograde axon cargo transport | 1.120533e-2 |
GO:0001830 | trophectodermal cell fate commitment | 1.120533e-2 |
GO:0060018 | astrocyte fate commitment | 1.131971e-2 |
GO:0035964 | COPI-coated vesicle budding | 1.132282e-2 |
GO:0042439 | ethanolamine-containing compound metabolic process | 1.138602e-2 |
GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway | 1.154656e-2 |
GO:0044273 | sulfur compound catabolic process | 1.154656e-2 |
GO:0014044 | Schwann cell development | 1.157890e-2 |
GO:0034284 | response to monosaccharide stimulus | 1.166880e-2 |
GO:0043254 | regulation of protein complex assembly | 1.185836e-2 |
GO:0001508 | regulation of action potential | 1.197492e-2 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 1.201268e-2 |
GO:0044272 | sulfur compound biosynthetic process | 1.207412e-2 |
GO:0006290 | pyrimidine dimer repair | 1.212198e-2 |
GO:0008595 | anterior/posterior axis specification, embryo | 1.221079e-2 |
GO:0031054 | pre-miRNA processing | 1.228866e-2 |
GO:0034380 | high-density lipoprotein particle assembly | 1.230287e-2 |
GO:0050848 | regulation of calcium-mediated signaling | 1.240830e-2 |
GO:0071260 | cellular response to mechanical stimulus | 1.269311e-2 |
GO:0030838 | positive regulation of actin filament polymerization | 1.280286e-2 |
GO:0019370 | leukotriene biosynthetic process | 1.284605e-2 |
GO:0031100 | organ regeneration | 1.288068e-2 |
GO:0007422 | peripheral nervous system development | 1.292550e-2 |
GO:0032763 | regulation of mast cell cytokine production | 1.313737e-2 |
GO:0019377 | glycolipid catabolic process | 1.318413e-2 |
GO:0043173 | nucleotide salvage | 1.329457e-2 |
GO:0051643 | endoplasmic reticulum localization | 1.329457e-2 |
GO:0021562 | vestibulocochlear nerve development | 1.329457e-2 |
GO:0019448 | L-cysteine catabolic process | 1.329457e-2 |
GO:0009115 | xanthine catabolic process | 1.329457e-2 |
GO:0009154 | purine ribonucleotide catabolic process | 1.333114e-2 |
GO:0071480 | cellular response to gamma radiation | 1.345459e-2 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 1.347025e-2 |
GO:0021603 | cranial nerve formation | 1.355065e-2 |
GO:0018106 | peptidyl-histidine phosphorylation | 1.355065e-2 |
GO:0000209 | protein polyubiquitination | 1.375586e-2 |
GO:0042373 | vitamin K metabolic process | 1.380487e-2 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.380487e-2 |
GO:0034059 | response to anoxia | 1.380487e-2 |
GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1.380487e-2 |
GO:0021527 | spinal cord association neuron differentiation | 1.388020e-2 |
GO:0071879 | positive regulation of adrenergic receptor signaling pathway | 1.391974e-2 |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 1.391974e-2 |
GO:0002730 | regulation of dendritic cell cytokine production | 1.391974e-2 |
GO:0045648 | positive regulation of erythrocyte differentiation | 1.404397e-2 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.411275e-2 |
GO:0030195 | negative regulation of blood coagulation | 1.411779e-2 |
GO:0006778 | porphyrin-containing compound metabolic process | 1.421760e-2 |
GO:0001894 | tissue homeostasis | 1.422725e-2 |
GO:0006534 | cysteine metabolic process | 1.441221e-2 |
GO:0007005 | mitochondrion organization | 1.453642e-2 |
GO:0032963 | collagen metabolic process | 1.454437e-2 |
GO:0046549 | retinal cone cell development | 1.466500e-2 |
GO:0032273 | positive regulation of protein polymerization | 1.468319e-2 |
GO:0006144 | purine base metabolic process | 1.469591e-2 |
GO:0006000 | fructose metabolic process | 1.469591e-2 |
GO:0045454 | cell redox homeostasis | 1.474783e-2 |
GO:0032862 | activation of Rho GTPase activity | 1.486052e-2 |
GO:2000015 | regulation of determination of dorsal identity | 1.494636e-2 |
GO:0006705 | mineralocorticoid biosynthetic process | 1.494636e-2 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.494636e-2 |
GO:0006027 | glycosaminoglycan catabolic process | 1.494636e-2 |
GO:0060047 | heart contraction | 1.497030e-2 |
GO:0048706 | embryonic skeletal system development | 1.499265e-2 |
GO:0042391 | regulation of membrane potential | 1.507840e-2 |
GO:0090150 | establishment of protein localization in membrane | 1.509591e-2 |
GO:0045010 | actin nucleation | 1.509591e-2 |
GO:0043101 | purine-containing compound salvage | 1.509591e-2 |
GO:0042278 | purine nucleoside metabolic process | 1.527912e-2 |
GO:0051129 | negative regulation of cellular component organization | 1.540685e-2 |
GO:0043096 | purine base salvage | 1.548515e-2 |
GO:0035566 | regulation of metanephros size | 1.548515e-2 |
GO:0043306 | positive regulation of mast cell degranulation | 1.557125e-2 |
GO:0070541 | response to platinum ion | 1.557125e-2 |
GO:0006658 | phosphatidylserine metabolic process | 1.557125e-2 |
GO:0050808 | synapse organization | 1.563308e-2 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 1.577055e-2 |
GO:0015914 | phospholipid transport | 1.585493e-2 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 1.588679e-2 |
GO:0045217 | cell-cell junction maintenance | 1.588679e-2 |
GO:0030157 | pancreatic juice secretion | 1.588679e-2 |
GO:0032439 | endosome localization | 1.604822e-2 |
GO:0015993 | molecular hydrogen transport | 1.604822e-2 |
GO:0046394 | carboxylic acid biosynthetic process | 1.606017e-2 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1.608556e-2 |
GO:0060998 | regulation of dendritic spine development | 1.611233e-2 |
GO:0018022 | peptidyl-lysine methylation | 1.611819e-2 |
GO:0042133 | neurotransmitter metabolic process | 1.657494e-2 |
GO:0006816 | calcium ion transport | 1.659923e-2 |
GO:0031398 | positive regulation of protein ubiquitination | 1.663027e-2 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.675709e-2 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1.675709e-2 |
GO:0035524 | proline transmembrane transport | 1.676241e-2 |
GO:0046479 | glycosphingolipid catabolic process | 1.676241e-2 |
GO:0019054 | modulation by virus of host cellular process | 1.679809e-2 |
GO:0021700 | developmental maturation | 1.682761e-2 |
GO:0033700 | phospholipid efflux | 1.685604e-2 |
GO:0048676 | axon extension involved in development | 1.698894e-2 |
GO:0034655 | nucleobase-containing compound catabolic process | 1.701901e-2 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 1.716925e-2 |
GO:0009395 | phospholipid catabolic process | 1.721004e-2 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 1.729544e-2 |
GO:0021563 | glossopharyngeal nerve development | 1.732352e-2 |
GO:0050771 | negative regulation of axonogenesis | 1.742881e-2 |
GO:0015804 | neutral amino acid transport | 1.764186e-2 |
GO:0072523 | purine-containing compound catabolic process | 1.794769e-2 |